News

Karen Smith, doctoral student in Health Policy / Decision Sciences, was awarded a graduate research fellowship from the National Science Foundation (NSF). Begun in 1952, the NSF’s Graduate Research Fellowship

CHDS faculty Eve Wittenberg mentored students from across the globe in a “policy hackathon” devoted to developing policy proposals across the spectrum of COVID-related challenges.

CHDS welcomes Ye Shen, Radhika Tampi and Raj Vatsa to the PhD Program in Health Policy Decision Science track beginning Fall 2020. Ye Shen graduated from Johns Hopkins with an MSPH

On September 21-25, CHDS Deputy Director Lisa A. Robinson is teaching a new on-line short course, Benefit-Cost Analysis: Valuing Life and Health.

While the global pandemic has made the Fall of 2020 seem ridden with uncertainty, it has also offered glimmers of hope and purpose. For the incoming students starting at

In a recently published study, Eric Ross from McLean Hospital and CHDS’ Djøra Soeteman showed that Esketamine can be cost-effective for patients with treatment-resistant depression if the price drops by

CHDS Post-Doctoral Fellow Allison Portnoy and Faculty Stéphane Verguet with others published an article in Value in Health about the two main delivery platforms of the measles vaccine

Survivors of childhood cancer previously treated with chest radiation are at high risk of developing secondary breast cancer. Similar to BRCA1 mutation carriers, an estimated 30% of these survivors will develop

On Thursday, July 16, 2020, the Learning Network for Countries in Transitions (LNCT) hosted a webinar discussion on the incremental costs of routine immunization, campaigns, and outreach services

The COVID-19 crisis has focused unprecedented attention on the use of benefit-cost analysis and approaches for valuing mortality risk reductions, commonly referred to as the